Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
Identifieur interne : 000180 ( Pmc/Curation ); précédent : 000179; suivant : 000181Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
Auteurs : Rita Valenzuela [Espagne] ; Maria A. Costa-Besada [Espagne] ; Javier Iglesias-Gonzalez [Royaume-Uni] ; Emma Perez-Costas [États-Unis] ; Bego A Villar-Cheda [Espagne] ; Pablo Garrido-Gil [Espagne] ; Miguel Melendez-Ferro [États-Unis] ; Ramon Soto-Otero [Espagne] ; Jose L. Lanciego [Espagne] ; Daniel Henrion [France] ; Rafael Franco [Espagne] ; Jose L. Labandeira-Garcia [Espagne]Source :
- Cell Death & Disease [ 2041-4889 ] ; 2016.
Abstract
The renin–angiotensin system (RAS) was initially considered as a circulating humoral system controlling blood pressure, being kidney the key control organ. In addition to the ‘classical' humoral RAS, a second level in RAS, local or tissular RAS, has been identified in a variety of tissues, in which local RAS play a key role in degenerative and aging-related diseases. The local brain RAS plays a major role in brain function and neurodegeneration. It is normally assumed that the effects are mediated by the cell-surface-specific G-protein-coupled angiotensin type 1 and 2 receptors (AT1 and AT2). A combination of
Url:
DOI: 10.1038/cddis.2016.327
PubMed: 27763643
PubMed Central: 5133991
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000181
Links to Exploration step
PMC:5133991Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration</title>
<author><name sortKey="Valenzuela, Rita" sort="Valenzuela, Rita" uniqKey="Valenzuela R" first="Rita" last="Valenzuela">Rita Valenzuela</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Costa Besada, Maria A" sort="Costa Besada, Maria A" uniqKey="Costa Besada M" first="Maria A" last="Costa-Besada">Maria A. Costa-Besada</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Iglesias Gonzalez, Javier" sort="Iglesias Gonzalez, Javier" uniqKey="Iglesias Gonzalez J" first="Javier" last="Iglesias-Gonzalez">Javier Iglesias-Gonzalez</name>
<affiliation wicri:level="1"><nlm:aff id="aff3"><institution>Healing Foundation Centre, The University of Manchester</institution>
, Manchester,<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Perez Costas, Emma" sort="Perez Costas, Emma" uniqKey="Perez Costas E" first="Emma" last="Perez-Costas">Emma Perez-Costas</name>
<affiliation wicri:level="1"><nlm:aff id="aff4"><institution>Department of Pediatrics-Pediatric Nephrology, University of Alabama at Birmingham</institution>
, Birmingham, AL,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Villar Cheda, Bego A" sort="Villar Cheda, Bego A" uniqKey="Villar Cheda B" first="Bego A" last="Villar-Cheda">Bego A Villar-Cheda</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Garrido Gil, Pablo" sort="Garrido Gil, Pablo" uniqKey="Garrido Gil P" first="Pablo" last="Garrido-Gil">Pablo Garrido-Gil</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Melendez Ferro, Miguel" sort="Melendez Ferro, Miguel" uniqKey="Melendez Ferro M" first="Miguel" last="Melendez-Ferro">Miguel Melendez-Ferro</name>
<affiliation wicri:level="1"><nlm:aff id="aff5"><institution>Department of Surgery-Pediatric, University of Alabama at Birmingham</institution>
, Birmingham, AL,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Soto Otero, Ramon" sort="Soto Otero, Ramon" uniqKey="Soto Otero R" first="Ramon" last="Soto-Otero">Ramon Soto-Otero</name>
<affiliation wicri:level="1"><nlm:aff id="aff6"><institution>Laboratory of Neurochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lanciego, Jose L" sort="Lanciego, Jose L" uniqKey="Lanciego J" first="Jose L" last="Lanciego">Jose L. Lanciego</name>
<affiliation wicri:level="1"><nlm:aff id="aff7"><institution>Neuroscience Department, Center for Applied Medical Research (CIMA, IdiSNA), University of Navarra</institution>
, Pamplona,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Henrion, Daniel" sort="Henrion, Daniel" uniqKey="Henrion D" first="Daniel" last="Henrion">Daniel Henrion</name>
<affiliation wicri:level="1"><nlm:aff id="aff8"><institution>MITOVASC Institute, INSERM U1083, CNRS UMR6214, University of Angers</institution>
, Angers,<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Franco, Rafael" sort="Franco, Rafael" uniqKey="Franco R" first="Rafael" last="Franco">Rafael Franco</name>
<affiliation wicri:level="1"><nlm:aff id="aff9"><institution>Laboratory of Molecular Neurobiology, Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona</institution>
, Barcelona,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Labandeira Garcia, Jose L" sort="Labandeira Garcia, Jose L" uniqKey="Labandeira Garcia J" first="Jose L" last="Labandeira-Garcia">Jose L. Labandeira-Garcia</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">27763643</idno>
<idno type="pmc">5133991</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133991</idno>
<idno type="RBID">PMC:5133991</idno>
<idno type="doi">10.1038/cddis.2016.327</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">000181</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000181</idno>
<idno type="wicri:Area/Pmc/Curation">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000180</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration</title>
<author><name sortKey="Valenzuela, Rita" sort="Valenzuela, Rita" uniqKey="Valenzuela R" first="Rita" last="Valenzuela">Rita Valenzuela</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Costa Besada, Maria A" sort="Costa Besada, Maria A" uniqKey="Costa Besada M" first="Maria A" last="Costa-Besada">Maria A. Costa-Besada</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Iglesias Gonzalez, Javier" sort="Iglesias Gonzalez, Javier" uniqKey="Iglesias Gonzalez J" first="Javier" last="Iglesias-Gonzalez">Javier Iglesias-Gonzalez</name>
<affiliation wicri:level="1"><nlm:aff id="aff3"><institution>Healing Foundation Centre, The University of Manchester</institution>
, Manchester,<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Perez Costas, Emma" sort="Perez Costas, Emma" uniqKey="Perez Costas E" first="Emma" last="Perez-Costas">Emma Perez-Costas</name>
<affiliation wicri:level="1"><nlm:aff id="aff4"><institution>Department of Pediatrics-Pediatric Nephrology, University of Alabama at Birmingham</institution>
, Birmingham, AL,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Villar Cheda, Bego A" sort="Villar Cheda, Bego A" uniqKey="Villar Cheda B" first="Bego A" last="Villar-Cheda">Bego A Villar-Cheda</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Garrido Gil, Pablo" sort="Garrido Gil, Pablo" uniqKey="Garrido Gil P" first="Pablo" last="Garrido-Gil">Pablo Garrido-Gil</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Melendez Ferro, Miguel" sort="Melendez Ferro, Miguel" uniqKey="Melendez Ferro M" first="Miguel" last="Melendez-Ferro">Miguel Melendez-Ferro</name>
<affiliation wicri:level="1"><nlm:aff id="aff5"><institution>Department of Surgery-Pediatric, University of Alabama at Birmingham</institution>
, Birmingham, AL,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Soto Otero, Ramon" sort="Soto Otero, Ramon" uniqKey="Soto Otero R" first="Ramon" last="Soto-Otero">Ramon Soto-Otero</name>
<affiliation wicri:level="1"><nlm:aff id="aff6"><institution>Laboratory of Neurochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lanciego, Jose L" sort="Lanciego, Jose L" uniqKey="Lanciego J" first="Jose L" last="Lanciego">Jose L. Lanciego</name>
<affiliation wicri:level="1"><nlm:aff id="aff7"><institution>Neuroscience Department, Center for Applied Medical Research (CIMA, IdiSNA), University of Navarra</institution>
, Pamplona,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Henrion, Daniel" sort="Henrion, Daniel" uniqKey="Henrion D" first="Daniel" last="Henrion">Daniel Henrion</name>
<affiliation wicri:level="1"><nlm:aff id="aff8"><institution>MITOVASC Institute, INSERM U1083, CNRS UMR6214, University of Angers</institution>
, Angers,<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Franco, Rafael" sort="Franco, Rafael" uniqKey="Franco R" first="Rafael" last="Franco">Rafael Franco</name>
<affiliation wicri:level="1"><nlm:aff id="aff9"><institution>Laboratory of Molecular Neurobiology, Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona</institution>
, Barcelona,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Labandeira Garcia, Jose L" sort="Labandeira Garcia, Jose L" uniqKey="Labandeira Garcia J" first="Jose L" last="Labandeira-Garcia">Jose L. Labandeira-Garcia</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2"><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Cell Death & Disease</title>
<idno type="eISSN">2041-4889</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The renin–angiotensin system (RAS) was initially considered as a circulating humoral system controlling blood pressure, being kidney the key control organ. In addition to the ‘classical' humoral RAS, a second level in RAS, local or tissular RAS, has been identified in a variety of tissues, in which local RAS play a key role in degenerative and aging-related diseases. The local brain RAS plays a major role in brain function and neurodegeneration. It is normally assumed that the effects are mediated by the cell-surface-specific G-protein-coupled angiotensin type 1 and 2 receptors (AT1 and AT2). A combination of <italic>in vivo (rats, wild-type mice and</italic>
knockout <italic>mice)</italic>
and <italic>in vitro</italic>
(primary mesencephalic cultures, dopaminergic neuron cell line cultures) experimental approaches (confocal microscopy, electron microscopy, laser capture microdissection, transfection of fluorescent-tagged receptors, treatments with fluorescent angiotensin, western blot, polymerase chain reaction, HPLC, mitochondrial respirometry and other functional assays) were used in the present study. We report the discovery of AT1 and AT2 receptors in brain mitochondria, particularly mitochondria of dopaminergic neurons. Activation of AT1 receptors in mitochondria regulates superoxide production, via Nox4, and increases respiration. Mitochondrial AT2 receptors are much more abundant and increase after treatment of cells with oxidative stress inducers, and produce, via nitric oxide, a decrease in mitochondrial respiration. Mitochondria from the nigral region of aged rats displayed altered expression of AT1 and AT2 receptors. AT2-mediated regulation of mitochondrial respiration represents an unrecognized primary line of defence against oxidative stress, which may be particularly important in neurons with increased levels of oxidative stress such as dopaminergic neurons. Altered expression of AT1 and AT2 receptors with aging may induce mitochondrial dysfunction, the main risk factor for neurodegeneration.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Death Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Death Dis</journal-id>
<journal-title-group><journal-title>Cell Death & Disease</journal-title>
</journal-title-group>
<issn pub-type="epub">2041-4889</issn>
<publisher><publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">27763643</article-id>
<article-id pub-id-type="pmc">5133991</article-id>
<article-id pub-id-type="pii">cddis2016327</article-id>
<article-id pub-id-type="doi">10.1038/cddis.2016.327</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration</article-title>
<alt-title alt-title-type="running">Mitochondrial angiotensin receptors in neurons</alt-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Valenzuela</surname>
<given-names>Rita</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="author-notes" rid="note1"><sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Costa-Besada</surname>
<given-names>Maria A</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="author-notes" rid="note1"><sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Iglesias-Gonzalez</surname>
<given-names>Javier</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Perez-Costas</surname>
<given-names>Emma</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Villar-Cheda</surname>
<given-names>Begoña</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Garrido-Gil</surname>
<given-names>Pablo</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Melendez-Ferro</surname>
<given-names>Miguel</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Soto-Otero</surname>
<given-names>Ramon</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lanciego</surname>
<given-names>Jose L</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Henrion</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Franco</surname>
<given-names>Rafael</given-names>
</name>
<xref ref-type="aff" rid="aff9">9</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Labandeira-Garcia</surname>
<given-names>Jose L</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label>
<institution>Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, CIMUS, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</aff>
<aff id="aff2"><label>2</label>
<institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED)</institution>
,<country>Madrid, Spain</country>
</aff>
<aff id="aff3"><label>3</label>
<institution>Healing Foundation Centre, The University of Manchester</institution>
, Manchester,<country>UK</country>
</aff>
<aff id="aff4"><label>4</label>
<institution>Department of Pediatrics-Pediatric Nephrology, University of Alabama at Birmingham</institution>
, Birmingham, AL,<country>USA</country>
</aff>
<aff id="aff5"><label>5</label>
<institution>Department of Surgery-Pediatric, University of Alabama at Birmingham</institution>
, Birmingham, AL,<country>USA</country>
</aff>
<aff id="aff6"><label>6</label>
<institution>Laboratory of Neurochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Santiago de Compostela</institution>
, Santiago de Compostela,<country>Spain</country>
</aff>
<aff id="aff7"><label>7</label>
<institution>Neuroscience Department, Center for Applied Medical Research (CIMA, IdiSNA), University of Navarra</institution>
, Pamplona,<country>Spain</country>
</aff>
<aff id="aff8"><label>8</label>
<institution>MITOVASC Institute, INSERM U1083, CNRS UMR6214, University of Angers</institution>
, Angers,<country>France</country>
</aff>
<aff id="aff9"><label>9</label>
<institution>Laboratory of Molecular Neurobiology, Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona</institution>
, Barcelona,<country>Spain</country>
</aff>
</contrib-group>
<author-notes><corresp id="caf1"><label>*</label>
<institution>Department of Morphological Sciences, Laboratory of Neuroanatomy and Experimental Neurology, Faculty of Medicine, University of Santiago de Compostela</institution>
, Santiago de Compostela 15782, <country>Spain</country>
. Tel: +34 881 812 223; Fax: +34 881 812 378; E-mail: <email>joseluis.labandeira@usc.es</email>
</corresp>
<fn fn-type="present-address" id="note1"><label>10</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub"><month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub"><day>20</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>1</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>7</volume>
<issue>10</issue>
<fpage>e2427</fpage>
<lpage></lpage>
<history><date date-type="received"><day>27</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="rev-recd"><day>14</day>
<month>09</month>
<year>2016</year>
</date>
<date date-type="accepted"><day>16</day>
<month>09</month>
<year>2016</year>
</date>
</history>
<permissions><copyright-statement>Copyright © 2016 The Author(s)</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><pmc-comment>author-paid</pmc-comment>
<license-p><italic>Cell Death and Disease</italic>
is an open-access journal published by <italic>Nature Publishing Group</italic>
. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>
</license-p>
</license>
</permissions>
<abstract><p>The renin–angiotensin system (RAS) was initially considered as a circulating humoral system controlling blood pressure, being kidney the key control organ. In addition to the ‘classical' humoral RAS, a second level in RAS, local or tissular RAS, has been identified in a variety of tissues, in which local RAS play a key role in degenerative and aging-related diseases. The local brain RAS plays a major role in brain function and neurodegeneration. It is normally assumed that the effects are mediated by the cell-surface-specific G-protein-coupled angiotensin type 1 and 2 receptors (AT1 and AT2). A combination of <italic>in vivo (rats, wild-type mice and</italic>
knockout <italic>mice)</italic>
and <italic>in vitro</italic>
(primary mesencephalic cultures, dopaminergic neuron cell line cultures) experimental approaches (confocal microscopy, electron microscopy, laser capture microdissection, transfection of fluorescent-tagged receptors, treatments with fluorescent angiotensin, western blot, polymerase chain reaction, HPLC, mitochondrial respirometry and other functional assays) were used in the present study. We report the discovery of AT1 and AT2 receptors in brain mitochondria, particularly mitochondria of dopaminergic neurons. Activation of AT1 receptors in mitochondria regulates superoxide production, via Nox4, and increases respiration. Mitochondrial AT2 receptors are much more abundant and increase after treatment of cells with oxidative stress inducers, and produce, via nitric oxide, a decrease in mitochondrial respiration. Mitochondria from the nigral region of aged rats displayed altered expression of AT1 and AT2 receptors. AT2-mediated regulation of mitochondrial respiration represents an unrecognized primary line of defence against oxidative stress, which may be particularly important in neurons with increased levels of oxidative stress such as dopaminergic neurons. Altered expression of AT1 and AT2 receptors with aging may induce mitochondrial dysfunction, the main risk factor for neurodegeneration.</p>
</abstract>
</article-meta>
</front>
<floats-group><fig id="fig1"><label>Figure 1</label>
<caption><p>Specificity of angiotensin receptor antibodies and localization of angiotensin receptors in mitochondria of dopaminergic neurons. (<bold>a</bold>
) The expression of major RAS components in dopaminergic neurons was confirmed by RT-PCR and laser microdissection of dopaminergic neurons retrogradly labeled by intrastriatal injection of fluorescent red retrobeads (RRB). SN section showing labeled dopaminergic neurons before and after laser microdissection for RT-PCR. Expression of TH, AGT, AT1, AT2 and <italic>β</italic>
-actin mRNA in laser-microdissected dopaminergic neurons (right) and homogenates of SN used as a positive control (left) are also shown. (<bold>b</bold>
) Western blot densitometric bands corresponding to 10 <italic>μ</italic>
g of AT1 or AT2 receptor overexpression lysate containing a C-terminal DDK epitope tag (DYKDDDDK) fused (left), and 10 <italic>μ</italic>
g of empty vector transfected control cell lysate HEK293 (EV, right). A band of 45 kDa was detected with the AT1 antibody, while a band of 50 kDa was detected with the AT2 antibody. A monoclonal antibody against DDK detected the corresponding band in the protein lysates. Colocalization of mitochondria and AT1 and AT2 receptors in primary cultures of the nigral region (<bold>c</bold>
) and neurons from the MES 23.5 dopaminergic cell line (<bold>d</bold>
). Electron microscopy of AT1 and AT2 labeling in a neuronal process (<bold>e</bold>
) and cytoplasm (<bold>f</bold>
) of a dopaminergic neuron. Immunolabeling for AT1 was observed in the outer membrane and cristae (white arrows) of mitochondria. In addition, strong AT1 labeling was also seen in clusters of free ribosomes (empty arrowheads). Immunolabeling for AT2 was present in mitochondrial membranes (white arrows), in the rough endoplasmic reticulum (black arrowheads) and in small clusters of free ribosomes, some of which were in close proximity to labeled mitochondria (empty arrowheads). AGT, angiotensinogen; DA, dopaminergic; MTDR, MitoTracker Deep Red; SN, substantia nigra; TH, tyrosine hydroxylase. Scale bars: (<bold>a</bold>
) 50 and 200 <italic>μ</italic>
m (SN section); (<bold>c</bold>
) 5 <italic>μ</italic>
m; (<bold>d</bold>
) 10 <italic>μ</italic>
m; (<bold>e</bold>
and <bold>f</bold>
) 500 nm</p>
</caption>
<graphic xlink:href="cddis2016327f1"></graphic>
</fig>
<fig id="fig2"><label>Figure 2</label>
<caption><p>Presence of fluorescence-tagged angiotensin receptors and fluorescent angiotensin II in mitochondria. Colocalization (<bold>c</bold>
, <bold>f</bold>
and <bold>i</bold>
) of the fluorescent mitochondrial marker MTDR (<bold>a</bold>
, <bold>d</bold>
and <bold>g</bold>
) with AT2-YFP (<bold>b</bold>
), AT1-EGFP (<bold>e</bold>
) or AII-488 (<bold>h</bold>
). Fluorescent AII-488 colocalized with mitochondria 8 h after treatment of cultures (<bold>g–i</bold>
). Cells transfected with AT1-EGFP required simultaneous treatment with the AT1 receptor antagonist losartan, in order to minimize AT1-induced superoxide toxicity and cell death. AT2-YFP, angiotensin receptor type 2 tagged to yellow fluorescent protein; AT1-EGFP, angiotensin receptor type 1 tagged to enhanced green fluorescent protein; AII-488, Alexa Fluor 488-fluorescent angiotensin II; MTDR, MitoTracker Deep Red. Scale bar: 5 <italic>μ</italic>
m</p>
</caption>
<graphic xlink:href="cddis2016327f2"></graphic>
</fig>
<fig id="fig3"><label>Figure 3</label>
<caption><p>AT1 and AT2 receptors in isolated mitochondria (IM) from ventral mesencephalon and the dopaminergic neuron cell line MES 23.5. Effect of oxidative stress and aging. (<bold>a–c</bold>
) Western blot (WB) of whole homogenate (Wh; <italic>n</italic>
=4) and pure IM (Mt; <italic>n</italic>
=4) from the nigral region (<bold>a</bold>
) and MES 23.5 cells (<bold>c</bold>
) showing different compartment markers used to assess the purity of the IM: voltage-dependent anion channel (VDAC) as a mitochondrial marker, tubulin as a cytosol marker and histone deacetylase 2 (HDAC2) as a nuclear marker. Note the higher expression of mitochondrial AT2 compared with AT1 receptors (<bold>b</bold>
). (<bold>d</bold>
)The levels of lactate dehydrogenase specific activity (LDH; micromol of substrate/min/mg; a marker for cytosolic and synaptosomal contamination) of the nigral region and MES 23.5 pure IM (Mt; <italic>n</italic>
=6) were negligible relative to those in Wh. (<bold>e</bold>
and <bold>f</bold>
) WB of IM from the MES 23.5 cells transfected with AT2-YFP (yellow fluorescent protein; <italic>n</italic>
=4) or AT1-EGFP (enhanced green fluorescent protein; <italic>n</italic>
=3) showing the presence of fluorescent-tagged angiotensin receptors in IM in comparison with non-transfected cells (Co, control); 24 h treatment of cells, low doses of MPP<sup>+</sup>
(<italic>n</italic>
=4) or <italic>N</italic>
-acetyl-<sc>l</sc>
-cysteine (NAC; <italic>n</italic>
=3) induced increased expression of mitochondrial AT2 and AT1 receptors, respectively (AT2-YFP+MPP<sup>+</sup>
; AT1-EGFP+NAC). (<bold>g–i</bold>
) In young (<italic>n</italic>
=3) and aged (<italic>n</italic>
=4) rats, the expression of AT1 and AT2 receptors was analyzed by RT-PCR in nigral dopaminergic neurons labeled with red retrobeads (RRB) and isolated by laser microdissection (<bold>g–h</bold>
), and by WB of IM from the nigral region of young (<italic>n</italic>
=5–8) and aged rats (<italic>n</italic>
=5-6) (<bold>i</bold>
). Aging induced a significant increase in AT1 expression and a significant decrease in AT2 expression in both dopaminergic neurons and in IM. The results were normalized to the values of young animals. Data are means±S.E.M. *<italic>P</italic>
<0.05 relative to the corresponding controls (Student's <italic>t</italic>
-test). Scale bars: 50 <italic>μ</italic>
m</p>
</caption>
<graphic xlink:href="cddis2016327f3"></graphic>
</fig>
<fig id="fig4"><label>Figure 4</label>
<caption><p>Effect of mitochondrial angiotensin receptors on mitochondrial respiration. (<bold>a</bold>
and <bold>b</bold>
) Activation of mitochondrial AT1 receptors with AII (i.e. AII+ PD123,319) induces an increase in both oxidative phosphorylation (P) and maximum respiratory rate (E), which was inhibited by pre-treatment of isolated mitochondria with the NOX4 inhibitor thioridazine (<italic>n</italic>
=3–8). (<bold>c</bold>
and <bold>d</bold>
) Knockout mice for AT1 receptors (KO AT1; <italic>n</italic>
=5) show lower mitochondrial respiration rates compared with wild-type littermate controls (WT). (<bold>e</bold>
and <bold>f</bold>
) Activation of mitochondrial AT2 receptors by AII (i.e. AII+losartan) produces a significant decrease in activated respiration (OXPHOS, P) and maximum respiration rate (maximum electron transport system, ETS, E) associated with complex I, which was blocked by pre-incubation of isolated mitochondria with the nitric oxide synthase (NOS) inhibitor, <italic>N<sup>ω</sup>
</italic>
-nitro-<sc>l</sc>
-arginine methyl ester hydrochloride (<sc>l</sc>
-NAME; <italic>n</italic>
=5–8). (<bold>g</bold>
and <bold>h</bold>
) Mice lacking AT2 receptors (KO AT2; <italic>n</italic>
=5) show an increased respiratory activity compared with wild-type mice (WT). Data are mean±S.E.M. *<italic>P</italic>
<0.05 compared with control. <sup>#</sup>
<italic>P</italic>
<0.05 compared with the group treated with AII. One-way analysis of variance (ANOVA) and Bonferroni <italic>post hoc</italic>
test (<bold>a</bold>
, <bold>b</bold>
, <bold>e</bold>
, <bold>f</bold>
) and Student's <italic>t</italic>
-test(<bold>c</bold>
, <bold>d</bold>
, <bold>g</bold>
, <bold>h</bold>
)</p>
</caption>
<graphic xlink:href="cddis2016327f4"></graphic>
</fig>
<fig id="fig5"><label>Figure 5</label>
<caption><p>Effect of mitochondrial angiotensin receptors on mitochondrial transmembrane potential, nitric oxide and superoxide production. (<bold>a</bold>
) In isolated mitochondria, activation of AT1 and AT2 receptors (AII+ the AT2 blocker PD123,319, and AII+ the AT1 blocker losartan, respectively) did not induce any significant change in mitochondrial membrane potential maintenance; however, the potassium ionophore valinomycin led to loss of approximately 40% of transmembrane potential relative to non-treated mitochondria (<italic>n</italic>
=5). (<bold>b</bold>
) Activation of AT2 receptors (AII+ the AT1 blocker losartan) induced an increase in levels of NO that was inhibited by pre-treatment with the NOS inhibitor <sc>l</sc>
-NAME (<italic>n</italic>
=5–8). (<bold>c</bold>
) The presence of Nox4 in isolated mitochondria was also shown by western blot assay with a rabbit monoclonal anti-Nox4 antibody, which detected a band of 60 kDa, and an antibody against the mitochondrial marker VDAC. The Nox4 signal increased with mitochondrial content (5, 10, 50 <italic>μ</italic>
g of mitochondrial sample loaded in the acrylamide gel). (<bold>d</bold>
) In isolated mitochondria, activation of AT1 receptors with AII (AII+the AT2 receptor antagonist PD123,319) resulted in increased levels of superoxide, and simultaneous treatment with the NOX4 inhibitor thioridazine led to the inhibition of total superoxide to about a 40% of untreated controls (<italic>n</italic>
=4–8). Data are mean±S.E.M. *<italic>P</italic>
<0.05 compared with control. <sup>#</sup>
<italic>P</italic>
<0.05 compared with the group treated with AII (one-way analysis of variance (ANOVA) and Bonferroni <italic>post hoc</italic>
test). <sc>l</sc>
-NAME, <sc>l</sc>
-arginine methyl ester hydrochloride; NOS, nitric oxide synthase</p>
</caption>
<graphic xlink:href="cddis2016327f5"></graphic>
</fig>
<fig id="fig6"><label>Figure 6</label>
<caption><p>Model of the role that AT1 and AT2 receptors play in modulating oxidative phosphorylation in brain mitochondria. Activation of AT1 receptors in mitochondria regulates superoxide production, via Nox4, and increases respiration. Mitochondrial AT2 receptors are much more abundant and induce, via nitric oxide, a decrease in mitochondrial respiration, modulating oxidative phosphorylation without significant alteration in mitochondrial membrane potential, which indicates that the bioenergetic properties of the mitochondria are not affected. Mitochondrial AT2 receptor expression increased after treatment of cells with oxidative stress (OS) inducers (such as low doses of MPP<sup>+</sup>
) and decreased with aging. Mitochondrial AT1 expression increased with aging and after treatment of cells with antioxidants (such as <italic>N</italic>
-acetyl-cysteine, NAC). At mitochondrial level, AT2 receptors may act as respiratory modulators and counteract low levels of OS, which may be particularly important in cells with an increase in levels of OS such as dopaminergic neurons. Aging induces altered expression of mitochondrial AT1 and AT2 receptors that may induce mitochondrial dysfunction, the main risk factor for neurodegeneration</p>
</caption>
<graphic xlink:href="cddis2016327f6"></graphic>
</fig>
</floats-group>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000180 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000180 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:5133991 |texte= Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:27763643" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |